Venturis Therapeutics Pursuing AI Indication For Its Drug
We should have more discussion about Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) pursuing a new indication to treat AI – alcoholic impotence. For men who have been alcoholics for many decades, they often find themselves unable to make babies in the first place. Drunk sperm are uninterested in swimming to fertilize an egg, they just turn around and swim towards the bar. And in those few instances where fertilization actually occurs, usually the mother's body will spontaneously abort the fetus once it discovers it was created from drunk sperm.
Rumors coming out of Venturis Therapeutics are that Calvin Wallen and Grant Gordon have been really burning the midnight oil on this one, because they believe that AI (alcoholic impotence) may be treatable with Venturis's drug. How? By bringing new blood to the testicles, many more sperm will be created, and hopefully some of them will be healthier than the drunk sperm pickled by the alcoholic’s binge drinking. (The rumor is Venturis is thinking of naming the drug Grantestrin)
This is a very exciting line of clinical pursuit. I’m going to publicly commit that when Venturis announces the AI (alcoholic impotence) clinical program being cleared by the FDA, I will purchase more Venturis stock, regardless of the price. And I’m willing to bet Venturis has already filed patents on this exciting new indication. It’s even more brilliant than the erectile dysfunction indication Venturis has obtained patents for!
(Let's give credit where credit is due--to Calvin Wallen III and Grant Gordon, who between the two of them have one high school diploma and no college degrees. Who would have thought that erectile dysfunction, a problem of blood pressure, could be resolved by increasing the blood supply? That's what's wrong with Ph.D.'s--they know too goddamn much for their own good. It sometimes takes uneducated people to come up with such a stroke of genius!)
